(Q47615801)

English

A novel antidiabetic drug, troglitazone--reason for hope and concern.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

editorial

0 references

title

A novel antidiabetic drug, troglitazone--reason for hope and concern. (English)

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

author name string

H Imura

series ordinal

1

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

language of work or name

English

0 references

publication date

1 March 1998

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

volume

338

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

page(s)

908-909

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

issue

13

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

Identifiers

DOI

10.1056/NEJM199803263381311

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

PubMed ID

9516229

1 reference

stated in

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/9516229

(Q47615801)

A novel antidiabetic drug, troglitazone--reason for hope and concern.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)